Combination & Conjugate Vaccines

Increasingly, more diseases are becoming vaccine preventable, but maintaining community and provider acceptance demands that the number of injections doesn’t increase. Combination conjugate vaccines represent an inevitable and important advance. This paper reviews the efficacy and safety of combination conjugate vaccines, including immunological mechanisms underlying interactions among vaccine epitopes, the role of immunological memory, and correlates of immunity. Specific attention is given to the experience with combination vaccines against each of Haemophilus influenzae type b, Streptococcus pneumoniae and Neisseria meningitidis. The implications of these findings for different communities are discussed, key areas for further research identified and implications for post-licensure monitoring addressed.

 


 

    Related Conference of Combination & Conjugate Vaccines

    June 23-24, 2021

    34th World Congress on Vaccines and Immunization

    Osaka, Australia
    June 24-25, 2021

    9th World Summit on immunology & immunotherapy

    Prague, Czech Republic
    June 29-29, 2021

    3rd International Conference on Dermatology and Allergic Diseases

    Singapore City, Singapore
    July 08-09, 2021

    International Online Conference on Immunology

    New York, USA
    August 27-28, 2021

    5th International Conference on Emerging Infectious Diseases

    Amsterdam, Netherlands
    October 12-13, 2021

    International Conference on Vaccine and Vaccine research

    Manila, Philippines
    October 14-15, 2021

    13th Annual Conference on Clinical Immunology

    Cape Town, South Africa
    October 14-15, 2021

    11th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa
    November 10-11, 2021

    International Conference on Immunology Research

    New York, USA

    Combination & Conjugate Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in